🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: AZD2936

Found 26 matching trials

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

PHASE3

The purpose of this study is to measure the efficacy and safety of rilvegos...

Status

Recruiting

Location

Research Site

Start Date

2025-12-04

Trial ID

NCT07221253

Treatments Being Tested

Rilvegostomig Durvalumab Gemcitabine/Cisplatin

Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)

PHASE2

DESTINY-Gastric03 will investigate the safety, tolerability, pharmacokineti...

Status

Active Not Recruiting

Location

Research Site

Start Date

2020-06-03

Trial ID

NCT04379596

Treatments Being Tested

Fluorouracil (5-FU)Capecitabine Durvalumab Oxaliplatin Trastuzumab Trastuzumab deruxtecan Cisplatin Pembrolizumab Volrustomig Rilvegostomig

A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC

PHASE1

This study is designed to determine the efficacy and safety of durvalumab a...

Status

Active Not Recruiting

Location

Research Site

Start Date

2018-12-27

Trial ID

NCT03819465

Treatments Being Tested

Durvalumab Danvatirsen Oleclumab MEDI5752 Pemetrexed Carboplatin Gemcitabine Cisplatin Nab-paclitaxel AZD2936

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

PHASE3

The purpose of this study is to evaluate the efficacy and safety of sonesit...

Status

Recruiting

Location

Research Site

Start Date

2026-02-03

Trial ID

NCT07431281

Treatments Being Tested

Sonesitatug vedotin Rilvegostomig Nivolumab Capecitabine 5-Fluorouracil Oxaliplatin Zolbetuximab Leucovorin

Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC

PHASE1

DESTINY-Lung03 will investigate the safety and tolerability of trastuzumab ...

Status

Recruiting

Location

Research Site

Start Date

2021-03-09

Trial ID

NCT04686305

Treatments Being Tested

T-DXd Durvalumab Cisplatin Carboplatin Pemetrexed Volrustomig Rilvegostomig

A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy

PHASE1

The purpose of this study is to determine the subcutaneous (SC) dose that g...

Status

Recruiting

Location

Research Site

Start Date

2025-11-25

Trial ID

NCT07161414

Treatments Being Tested

IV Rilvegostomig Recombinant Human Hyaluronidase (rHu)SC Rilvegostomig SC rilvegostomig + rHu

Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung Cancer

PHASE1

This study will assess safety, tolerability, and treatment activity of dato...

Status

Active Not Recruiting

Location

Research Site

Start Date

2021-02-02

Trial ID

NCT04612751

Treatments Being Tested

Datopotamab deruxtecan Durvalumab Carboplatin AZD2936 MEDI5752 AZD7789

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

PHASE1

This research study is studying a new compound, AZD8205, as a possible trea...

Status

Recruiting

Location

Research Site

Start Date

2021-10-18

Trial ID

NCT05123482

Treatments Being Tested

AZD8205 AZD8205 and AZD2936 (Rilvegostomig)AZD8205 and AZD5305 (saruparib)AZD8205 and AZD5305 (saruparib) and AZD2936 (rilvegostomig)AZD8205 in combination with AZD9574 AZD8205 in combination with AZD9574 plus rilvegostomig (AZD2936)

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

PHASE2

GEMINI-PeriOp GC study will assess the safety, tolerability, pharmacokineti...

Status

Recruiting

Location

Research Site

Start Date

2025-07-17

Trial ID

NCT07069712

Treatments Being Tested

Sonesitatug Vedotin Rilvegostomig Trastuzumab Deruxtecan (T-DXd)Capecitabine 5-Fluorouracil (5-FU)FLOT Chemotherapy Calcium folinate

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

PHASE3

Purpose: to assess efficacy and safety of Dato-DXd + rilvegostomig as adjuv...

Status

Recruiting

Location

Research Site

Start Date

2026-07-16

Trial ID

NCT07720284

Treatments Being Tested

Dato-DXd Rilvegostomig Durvalumab Nivolumab Pembrolizumab Enfortumab vedotin

Previous Next